Top of page| DOCTOR FUNGUS
CME program - "Opportunistic Fungi in the Immunocompromised Patient" |
||
|
Faculty
|
||
|
No significant financial relationships with commercial entities were disclosed by: Dr. David P. Greenberg Dr. Carol A. Kauffman The following information was disclosed: Dr. Elias Anaissie Grant/research Pfizer, Fujisawa Consultant Pfizer, Ortho Biotech, Fujisawa Speakers Bureau Ortho Biotech, Fujisawa, Gilead Sciences Dr. Thomas Patterson Grant/research Pfizer, Janssen, Bristol-Myers Squibb, Schering, Merck, The Liposome Company Consultant Pfizer, Bristol-Myers Squibb, Merck, Ortho Biotech, Fujisawa Speakers Bureau Pfizer, Janssen, Bristol-Myers Squibb, The Liposome Company, Merck, Ortho Biotech, Schering Dr. John Rex Grant/research Pfizer, Merck, Fujisawa, Versicor, Aronex, Ortho Biotech, The Liposome Company Dr. Robert Rubin Grant/research Pfizer, Merck, Bristol-Myers Squibb Dr. Jack Sobel Grant/research Pfizer, 3M Consultant/Speakers Bureau Fujisawa | ||
| Close this window | ||